The latest closing stock price for Xeris Biopharma Holdings as of February 21, 2025 is 3.75.
An investor who bought $1,000 worth of Xeris Biopharma Holdings stock at the IPO in 2018 would have $-815 today, roughly -1 times their original investment - a -21.39% compound annual growth rate over 7 years.
The all-time high Xeris Biopharma Holdings stock closing price was 27.23 on September 10, 2018.
The Xeris Biopharma Holdings 52-week high stock price is 4.10, which is 9.3% above the current share price.
The Xeris Biopharma Holdings 52-week low stock price is 1.69, which is 54.9% below the current share price.
The average Xeris Biopharma Holdings stock price for the last 52 weeks is 2.71.
An investor who bought $1,000 worth of Xeris Biopharma Holdings stock at the IPO in 2018 would have $-815 today, roughly -1 times their original investment - a -21.39% compound annual growth rate over 7 years.
The all-time high Xeris Biopharma Holdings stock closing price was 27.23 on September 10, 2018.
The Xeris Biopharma Holdings 52-week high stock price is 4.10, which is 9.3% above the current share price.
The Xeris Biopharma Holdings 52-week low stock price is 1.69, which is 54.9% below the current share price.
The average Xeris Biopharma Holdings stock price for the last 52 weeks is 2.71.